About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PPIO-006 Primary Tumor Resection for IVa NSCLC | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT06232967

PPIO-006 Primary Tumor Resection for IVa NSCLC

The goal of this mutli-center observational study is toinvestigate the impact of primary tumor resection (PTR) on the long-term survival of patients with non-small-cell lung cancer (NSCLC) and dry ple...

Lead sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Collaborators

First Affiliated Hospital of Chongqing Medical University

Non-small-cell lung cancer (NSCLC) patients with dry pleural dissemination have poor survival rates and are generally contraindicated for surgery. Previous single-center retrospective studies have suggested that these patients may benefit from primary tumor resection (PTR). However, the evidence supporting PTR is still limited, especially in the era of targeted therapy. This study aimed to investigate the impact of PTR on the long-term survival of patients with NSCLC and DPD.

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•(1) pathologically confirmed primary NSCLC with malignant pleural dissemination, (2) no preoperative treatment, (3) age 80 years or younger, (4) clinicopathologic data and follow-up results were complete.

Exclusion Criteria

•(1) pleural effusion, contralateral lung metastasis or distant metastasis revealed preoperatively, and (2) with a history of other malignant disease.

Related studies

RECRUITINGPhase 2

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

NCT06693336 · Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)

RECRUITINGPhase 2/3

Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

NCT02448992 · Non-Small-Cell Lung Cancer (NSCLC), Brain Metastasis

A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

NCT03725475 · Non-small-cell Lung Cancer (NSCLC)

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

NCT03083743 · Non-small-cell Lung Cancer (NSCLC) Stage IV

A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer

NCT01874678 · Non-small-cell Lung Cancer (NSCLC)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 27, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment223

Start dateApr 2023

Last updatedJun 27, 2024

Condition

Non-small-cell Lung Cancer (NSCLC)

Locations shown

Army Medical Center of the People's Liberation Army

Chongqing, Chongqing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 27, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions